Gross Profit: Revenues from operations less the associated costs.
Ampio Pharmaceuticals, Inc. (AMPE) Gross Profit data is not available for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-8.63M |
|
-- |
|
|
Gross Profit |
-- |
$9.57M |
|
$-9.57M |
|
$0.94M |
|
$-8.63M |
|
$-8.63M |
|
$-8.63M |
|
$-8.63M |
|
$-8.63M |
|
$-8.63M |
|
$-9.57M |
|
$-9.45M |
|
0.81M |
|
0.81M |
|
$-10.66 |
|
$-10.66 |
|
| Balance Sheet Financials | |
$5.74M |
|
-- |
|
-- |
|
$5.74M |
|
$2.38M |
|
-- |
|
-- |
|
$2.38M |
|
$3.36M |
|
$3.36M |
|
$3.36M |
|
0.83M |
|
| Cash Flow Statement Financials | |
$-8.56M |
|
-- |
|
-- |
|
$12.65M |
|
$4.09M |
|
$-8.56M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-256.90% |
|
-256.90% |
|
-150.49% |
|
-256.90% |
|
$4.03 |
|
$-10.57 |
|
$-10.57 |
|